Pemetrexed 500 mg

DRUG2 trials

Sponsors

Samsung Medical Center, Latin American Cooperative Oncology Group

Conditions

Biliary Tract CancerMetastatic Non-small Cell Lung Cancers

Phase 2

Pemetrexed in Combination With Erlotinib as a Salvage Treatment in Patients With Metastatic Biliary Tract Cancer (BTC) Who Failed Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study

Samsung Medical CenterBiliary Tract Cancer

Start: 2021-07-09End: 2024-06-14Target: 44Updated: 2022-06-15

Amivantamab, Lazertinib, and Pemetrexed for First-line Treatment of Recurrent/Metastatic Non-small Cell Lung Cancers With Epidermal Growth Factor Receptor Mutations

CompletedNCT05299125

Latin American Cooperative Oncology GroupMetastatic Non-small Cell Lung Cancers

Start: 2023-05-24End: 2025-11-21Updated: 2026-08-28